v3.25.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2025
Equity [Abstract]  
Summary of Restricted Stock Activity activity for the six months ended June 30, 2025 is summarized below:

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

average

 

 

 

 

 

 

 

 

 

 

 

 

grant

 

 

 

 

 

 

Performance

 

 

 

 

 

date fair

 

 

 

 

 

 

and

 

 

 

 

 

value

 

Restricted stock units

 

Time-based

 

 

time-based

 

 

Total

 

 

per share

 

Unvested restricted stock units as of December 31, 2024

 

 

1,203,383

 

 

 

601,194

 

 

 

1,804,577

 

 

$

8.61

 

Granted

 

 

926,671

 

 

 

822,308

 

 

 

1,748,979

 

 

 

9.19

 

Vested

 

 

(394,503

)

 

 

(118,100

)

 

 

(512,603

)

 

 

10.12

 

Forfeited/canceled

 

 

(93,060

)

 

 

(110,118

)

 

 

(203,178

)

 

 

9.99

 

Unvested restricted stock units as of June 30, 2025 (1)

 

 

1,642,491

 

 

 

1,195,284

 

 

 

2,837,775

 

 

$

8.52

 

Unvested and expected to vest restricted stock units outstanding as of
      June 30, 2025

 

 

 

 

 

 

 

 

1,999,895

 

 

$

8.41

 

(1) Outstanding RSUs are based on the maximum payout of the targeted number of shares.

Summary of Stock-based Compensation Expense

Stock-based compensation expense recognized for the three and six months ended June 30, 2025 and 2024, was as follows:

 

 

 

Three months ended

 

 

Six months ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Stock-based compensation expense by type of award:

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock units

 

$

2,205

 

 

$

1,696

 

 

$

4,213

 

 

$

4,005

 

Employee stock purchase plan

 

 

88

 

 

 

118

 

 

 

227

 

 

 

225

 

Total stock-based compensation expense

 

$

2,293

 

 

$

1,814

 

 

$

4,440

 

 

$

4,230

 

S

For the three and six months ended June 30, 2025 and 2024, respectively, stock-based compensation expense recognized under ASC 718, included in cost of revenue, research and development expense, sales and marketing expense, and general and administrative expense was as follows:

 

 

Three months ended

 

 

Six months ended

 

 

 

June 30,

 

 

June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Cost of revenue

 

$

129

 

 

$

145

 

 

$

296

 

 

$

325

 

Research and development

 

 

69

 

 

 

(75

)

 

 

164

 

 

 

385

 

Sales and marketing

 

 

186

 

 

 

428

 

 

 

400

 

 

 

858

 

General and administrative

 

 

1,909

 

 

 

1,316

 

 

 

3,580

 

 

 

2,662

 

Total stock-based compensation expense

 

$

2,293

 

 

$

1,814

 

 

$

4,440

 

 

$

4,230